These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19577689)

  • 1. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Rosenstein R; Parra D
    Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577689
    [No Abstract]   [Full Text] [Related]  

  • 2. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Sniderman AD
    Lancet; 2009 Jul; 374(9683):25; author reply 26-7. PubMed ID: 19577690
    [No Abstract]   [Full Text] [Related]  

  • 3. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Danchin N
    Lancet; 2009 Jul; 374(9683):24-5; author reply 26-7. PubMed ID: 19577685
    [No Abstract]   [Full Text] [Related]  

  • 4. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Segura J; Ruilope LM
    Lancet; 2009 Jul; 374(9683):26; author reply 26-7. PubMed ID: 19577691
    [No Abstract]   [Full Text] [Related]  

  • 5. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Feeman WE
    Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577687
    [No Abstract]   [Full Text] [Related]  

  • 6. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    de Tena JG
    Lancet; 2009 Jul; 374(9683):24; author reply 26-7. PubMed ID: 19577686
    [No Abstract]   [Full Text] [Related]  

  • 7. Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial.
    Bloom JM
    Lancet; 2009 Jul; 374(9683):25-6; author reply 26-7. PubMed ID: 19577688
    [No Abstract]   [Full Text] [Related]  

  • 8. The JUPITER Trial: responding to the critics.
    Ridker PM; Glynn RJ
    Am J Cardiol; 2010 Nov; 106(9):1351-6. PubMed ID: 21029837
    [No Abstract]   [Full Text] [Related]  

  • 9. Bringing JUPITER down to earth.
    Després JP
    Lancet; 2009 Apr; 373(9670):1147-8. PubMed ID: 19329179
    [No Abstract]   [Full Text] [Related]  

  • 10. Rosuvastatin in patients with elevated C-reactive protein.
    Jenny-Avital ER
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
    [No Abstract]   [Full Text] [Related]  

  • 11. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
    Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
    Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
    [No Abstract]   [Full Text] [Related]  

  • 12. Rosuvastatin in patients with elevated C-reactive protein.
    Chan PS; Nallamothu BK; Hayward RA
    N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271273
    [No Abstract]   [Full Text] [Related]  

  • 13. JUPITER, rosuvastatin, and the European Medicines Agency.
    Ridker PM; Glynn RJ
    Lancet; 2010 Jun; 375(9731):2071. PubMed ID: 20494436
    [No Abstract]   [Full Text] [Related]  

  • 14. JUPITER study highlights value of anti-inflammatory action of rosuvastatin.
    Cardiovasc J Afr; 2009; 20(3):211. PubMed ID: 19575096
    [No Abstract]   [Full Text] [Related]  

  • 15. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 16. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
    Ridker PM;
    Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
    [No Abstract]   [Full Text] [Related]  

  • 17. Summaries for patients. Rosuvastatin to prevent heart problems and stroke in persons 70 years or older.
    Ann Intern Med; 2010 Apr; 152(8):I34. PubMed ID: 20404365
    [No Abstract]   [Full Text] [Related]  

  • 18. [JUPITER: reduction by rosuvastatin of cardiovascular events and mortality in healthy subjects without hyperlipidaemia but with elevated C-reactive protein].
    Scheen AJ
    Rev Med Liege; 2008 Dec; 63(12):749-53. PubMed ID: 19180837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
    Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
    Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statin cuts cardiovascular risk in half].
    Einecke D
    MMW Fortschr Med; 2008 Dec; 150(49-50):12-3. PubMed ID: 19133364
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.